Anika Therapeutics ANIK Earnings Call Transcripts

NASDAQ ANIK
$13.47 -1.10 (-7.55%)
At close: Nov 10, 2026 · 4:00 PM EST
13 earnings calls on file for Anika Therapeutics, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Anika Therapeutics Q2 2026 Earnings Call

Jul 29, 2026 5,207 words · 23 min read
  • Stephen D. GriffinPresident and Chief Executive Officer
  • Ian W. McLeodSenior Vice President, Chief Accounting Officer, and Treasurer
  • Matthew HallExecutive Director, Corporate Development and Investor Relations
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Anika Therapeutics Earnings Call Transcripts

Calls13
LatestJul 29, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 13 Anika Therapeutics transcripts Register to get access to Anika Therapeutics’s earnings call transcripts.